New York, New York--(Newsfile Corp. - August 5, 2026) - Kaplan Fox &amp; Kilsheimer LLP announces that a class action lawsuit has been filed against PROCEPT BioRobotics Corporation (&#34;PROCEPT&#34; or the

<p>New York, New York--(Newsfile Corp. - August 5, 2026) - <a href="https://api.newsfilecorp.com/redirect/kXVarFVZBE">Kaplan Fox &#38; Kilsheimer LLP</a> announces that a class action lawsuit has been filed against PROCEPT BioRobotics Corporation ("PROCEPT" or the "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/quote/PRCT">PRCT</a>) on behalf of all purchasers of PROCEPT common stock between February 28, 2024 and February 25, 2026 (the "Class Period").</p><p style="text-align: center;"><a href="https://api.newsfilecorp.com/redirect/B5oW1cpmvB">CLICK HERE TO JOIN THE CASE</a></p><p><b>If you are an investor in PROCEPT and have suffered losses, you may </b><a href="https://api.newsfilecorp.com/redirect/5WV1Yc5pLP"><b>CLICK HERE</b></a><b> to contact us. You may also contact Kaplan Fox by emailing </b><a href="mailto:pmayer@kaplanfox.com"><b>pmayer@kaplanfox.com</b></a><b> or by calling (646) 315-9003.</b></p><p><b>DEADLINE REMINDER: </b>If you are a member of the proposed Class, you may move the court <u><b>no later than September 22, 2026</b></u> to serve as a lead plaintiff for the purported class.  If you have losses we encourage you to contact us to learn more about the lead plaintiff process. You need not seek to become a lead plaintiff in order to share in any possible recovery.</p><p>The complaint alleges that contrary to defendants' Class Period assurances that the "differential" between handpiece unit sales and procedures had "remained relatively consistent," PROCEPT's discount program had caused handpiece orders to materially exceed procedures in every quarter during the Class Period. According to the complaint, these undisclosed sales tactics artificially inflated PROCEPT's reported U.S. handpiece unit sales and revenues by pulling forward demand at the expense of future periods.  </p><p><b>WHY CONTACT KAPLAN FOX?</b></p><p>Kaplan Fox &#38; Kilsheimer LLP is a nationally recognized law firm focused on complex litigation, with offices in New York, Oakland, Los Angeles, Chicago, and New Jersey. Founded in 1956, the firm has spent more than 50 years prosecuting securities, antitrust, and consumer protection actions in federal and state courts nationwide, recovering more than $10 billion for clients and the classes it has represented.</p><p>Kaplan Fox is widely regarded as one of the nation's premier plaintiffs' securities litigation firms and has received recognition from Chambers and Partners, Benchmark Litigation, Super Lawyers, and Lawdragon. Serving as lead or co-lead counsel in many landmark cases, the firm has secured some of the largest recoveries in the history of securities litigation, including a $2.425 billion recovery on behalf of Bank of America shareholders in <i>In re Bank of America</i>&#8212;the largest recovery ever obtained for claims under Section 14(a) of the Securities Exchange Act&#8212;$800 million recovered for the Arkansas Teacher Retirement System and other pension funds in <i>ATRS v. Allianz Global Investors</i>, and a $475 million settlement in <i>In re Merrill Lynch</i>.</p><p>For decades, Kaplan Fox has represented public pension funds, institutional investors, businesses, and individuals in high-stakes litigation. Through its successful advocacy and precedent-setting victories, the firm has helped shape important areas of securities and corporate law while advancing accountability and protecting investor interests.</p><p>This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules. Past results do not guarantee future outcomes.</p><p>If you have any questions about this Notice, your rights, or your interests, please contact:</p><div id="contactInfo"><p><b>CONTACT:</b><br />Pamela A. Mayer<br /><a href="https://api.newsfilecorp.com/redirect/LqN8JuDVE7">KAPLAN FOX &#38; KILSHEIMER LLP</a><br />800 Third Avenue, 38th Floor<br />New York, New York 10022<br />(646) 315-9003<br /><a href="mailto:pmayer@kaplanfox.com">pmayer@kaplanfox.com</a></p><p>Laurence D. King<br /><a href="https://api.newsfilecorp.com/redirect/oPv13FvX2j">KAPLAN FOX &#38; KILSHEIMER LLP</a><br />1999 Harrison Street, Suite 1501<br />Oakland, California 94612<br />(415) 772-4704<br /><a href="mailto:lking@kaplanfox.com">lking@kaplanfox.com</a></p></div><p>Contacting or submitting information to Kaplan Fox &#38; Kilsheimer LLP does not create an attorney-client relationship, nor an obligation on the part of Kaplan Fox to retain you as a client.</p><p id="corporateNewsLogoContainer"><img src="https://images.newsfilecorp.com/files/12532/308037_4cefc59e84b24ae1_logo.jpg" id="corporateNewsLogo" alt="Corporate Logo" /></p><p id="corporateLinkBack">To view the source version of this press release, please visit <a href="https://api.newsfilecorp.com/redirect/OArMmT3rXV">https://www.newsfilecorp.com/release/308037</a></p><p><img src="https://api.newsfilecorp.com/newsinfo/308037/197" alt="" /></p>

PRCT

Kaplan Fox Urges PROCEPT BioRobotics Corporation (PRCT) Investors Seeking Recovery to Contact the Firm Before September 28, 2026

Lawsuit Allegation Against PROCEPT Could Pressure PRCT Revenue Transparency and Valuation

<section class="insight" data-version="1">
  <section data-block="information">
    <h3>Information</h3>
    <p>New York, New York--(Newsfile Corp. - August 5, 2026) - Kaplan Fox &amp;amp; Kilsheimer LLP announces that a class action lawsuit has been filed against PROCEPT BioRobotics Corporation (&amp;#34;PROCEPT&amp;#34; or the</p>
  </section>

  <section data-block="ai-summary-paragraph">
    <h3>AI Summary</h3>
    <p>Kaplan Fox filed a class-action against PROCEPT alleging the company&#039;s discount program pulled forward handpiece orders, inflating U.S. sales during Feb 28, 2024 through Feb 25, 2026. The suit raises potential legal costs and could heighten investor concerns about revenue recognition and future profitability, potentially increasing near-term PRCT volatility as the case advances.</p>
  </section>

  <section data-block="ai-summary-bullets">
    <h3>Key Points</h3>
    <ul><li>Class-action targets PROCEPT over alleged undisclosed sales tactics inflating handpiece orders.</li><li>Lawsuit covers Feb 28, 2024 – Feb 25, 2026; lead plaintiff deadline Sept 22, 2026.</li><li>Allegations imply revenue may be pulled forward; impact on future periods unknown.</li><li>Plaintiff counsel Kaplan Fox and Kilsheimer LLP highlighted; no guaranteed recovery.</li><li>Regulatory or reputational impact could affect PRCT sentiment and volatility.</li></ul>
  </section>

  <section data-block="companies-mentioned">
    <h3>Companies Mentioned</h3>
    <ul><li><strong>PROCEPT BioRobotics Corporation (PRCT)</strong>: Subject of the class-action alleging revenue manipulation via handpiece discounts; potential litigation risk.</li><li><strong>Kaplan Fox &amp; Kilsheimer LLP (N/A)</strong>: Plaintiff counsel leading the suit; not a public company, but a driver of litigation visibility.</li><li><strong>Bank of America Corp (BAC)</strong>: Historical recoveries cited by plaintiffs&#039; counsel; backdrop context for litigation risk and settlement dynamics.</li></ul>
  </section>

  <section data-block="category">
    <h3>Legal</h3>
    <p>Category: Legal. The piece centers on a securities class-action filing against PRCT, signaling potential litigation risk and its impact on valuation, cash costs, and disclosures should the case progress.</p>
  </section>

  <section data-block="market-moving">
    <h3>Market-Moving</h3>
    <ul><li>PRCT shares may display increased volatility on lawsuit headlines.</li><li>No confirmed liability yet; outcome remains uncertain.</li><li>Settlement or disclosure could meaningfully move the stock.</li></ul>
  </section>

  <section data-block="key-facts">
    <h3>Key Facts</h3>
    <ul><li>Class Period: Feb 28, 2024 – Feb 25, 2026.</li><li>Lead plaintiff deadline: Sept 22, 2026.</li><li>Lawsuit filed by Kaplan Fox &amp; Kilsheimer LLP.</li><li>Allegation: undisclosed discount program inflated handpiece orders.</li></ul>
  </section>

  <section data-block="trading-thesis">
    <h3>Trading Thesis</h3>
    <p>Bearish-to-neutral near term; monitor case progress for potential material impact on revenue and cash costs.</p>
  </section>
</section>


<p>New York, New York--(Newsfile Corp. - August 5, 2026) - <a href="https://api.newsfilecorp.com/redirect/kXVarFVZBE">Kaplan Fox &#38; Kilsheimer LLP</a> announces that a class action lawsuit has been filed against PROCEPT BioRobotics Corporation ("PROCEPT" or the "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/quote/PRCT">PRCT</a>) on behalf of all purchasers of PROCEPT common stock between February 28, 2024 and February 25, 2026 (the "Class Period").</p><p style="text-align: center;"><a href="https://api.newsfilecorp.com/redirect/B5oW1cpmvB">CLICK HERE TO JOIN THE CASE</a></p><p><b>If you are an investor in PROCEPT and have suffered losses, you may </b><a href="https://api.newsfilecorp.com/redirect/5WV1Yc5pLP"><b>CLICK HERE</b></a><b> to contact us. You may also contact Kaplan Fox by emailing </b><a href="mailto:pmayer@kaplanfox.com"><b>pmayer@kaplanfox.com</b></a><b> or by calling (646) 315-9003.</b></p><p><b>DEADLINE REMINDER: </b>If you are a member of the proposed Class, you may move the court <u><b>no later than September 22, 2026</b></u> to serve as a lead plaintiff for the purported class.  If you have losses we encourage you to contact us to learn more about the lead plaintiff process. You need not seek to become a lead plaintiff in order to share in any possible recovery.</p><p>The complaint alleges that contrary to defendants' Class Period assurances that the "differential" between handpiece unit sales and procedures had "remained relatively consistent," PROCEPT's discount program had caused handpiece orders to materially exceed procedures in every quarter during the Class Period. According to the complaint, these undisclosed sales tactics artificially inflated PROCEPT's reported U.S. handpiece unit sales and revenues by pulling forward demand at the expense of future periods.  </p><p><b>WHY CONTACT KAPLAN FOX?</b></p><p>Kaplan Fox &#38; Kilsheimer LLP is a nationally recognized law firm focused on complex litigation, with offices in New York, Oakland, Los Angeles, Chicago, and New Jersey. Founded in 1956, the firm has spent more than 50 years prosecuting securities, antitrust, and consumer protection actions in federal and state courts nationwide, recovering more than $10 billion for clients and the classes it has represented.</p><p>Kaplan Fox is widely regarded as one of the nation's premier plaintiffs' securities litigation firms and has received recognition from Chambers and Partners, Benchmark Litigation, Super Lawyers, and Lawdragon. Serving as lead or co-lead counsel in many landmark cases, the firm has secured some of the largest recoveries in the history of securities litigation, including a $2.425 billion recovery on behalf of Bank of America shareholders in <i>In re Bank of America</i>&#8212;the largest recovery ever obtained for claims under Section 14(a) of the Securities Exchange Act&#8212;$800 million recovered for the Arkansas Teacher Retirement System and other pension funds in <i>ATRS v. Allianz Global Investors</i>, and a $475 million settlement in <i>In re Merrill Lynch</i>.</p><p>For decades, Kaplan Fox has represented public pension funds, institutional investors, businesses, and individuals in high-stakes litigation. Through its successful advocacy and precedent-setting victories, the firm has helped shape important areas of securities and corporate law while advancing accountability and protecting investor interests.</p><p>This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules. Past results do not guarantee future outcomes.</p><p>If you have any questions about this Notice, your rights, or your interests, please contact:</p><div id="contactInfo"><p><b>CONTACT:</b><br />Pamela A. Mayer<br /><a href="https://api.newsfilecorp.com/redirect/LqN8JuDVE7">KAPLAN FOX &#38; KILSHEIMER LLP</a><br />800 Third Avenue, 38th Floor<br />New York, New York 10022<br />(646) 315-9003<br /><a href="mailto:pmayer@kaplanfox.com">pmayer@kaplanfox.com</a></p><p>Laurence D. King<br /><a href="https://api.newsfilecorp.com/redirect/oPv13FvX2j">KAPLAN FOX &#38; KILSHEIMER LLP</a><br />1999 Harrison Street, Suite 1501<br />Oakland, California 94612<br />(415) 772-4704<br /><a href="mailto:lking@kaplanfox.com">lking@kaplanfox.com</a></p></div><p>Contacting or submitting information to Kaplan Fox &#38; Kilsheimer LLP does not create an attorney-client relationship, nor an obligation on the part of Kaplan Fox to retain you as a client.</p><p id="corporateNewsLogoContainer"><img src="https://images.newsfilecorp.com/files/12532/308037_4cefc59e84b24ae1_logo.jpg" id="corporateNewsLogo" alt="Corporate Logo" /></p><p id="corporateLinkBack">To view the source version of this press release, please visit <a href="https://api.newsfilecorp.com/redirect/OArMmT3rXV">https://www.newsfilecorp.com/release/308037</a></p><p><img src="https://api.newsfilecorp.com/newsinfo/308037/197" alt="" /></p>

Kaplan Fox filed a class-action against PROCEPT alleging the company's discount program pulled forward handpiece orders, inflating U.S. sales during Feb 28, 2024 through Feb 25, 2026. The suit raises potential legal costs and could heighten investor concerns about revenue recognition and future profitability, potentially increasing near-term PRCT volatility as the case advances.

News insight

Kaplan Fox Urges PROCEPT BioRobotics Corporation (PRCT) Investors Seeking Recovery to Contact the Firm Before September 28, 2026

AI summary

Sentiment rationale

Key facts

Legal